Delayed onset of sevoflurane-induced juvenile malignant hyperthermia after second exposure.
Malignant hyperthermia (MH) is a rare condition consisting of increased temperature and rigidity with mild to fulminant manifestation during anesthesia. Sevoflurane was thought to be a less potent triggering agent of MH; however, in literature review, the onset of MH after exposure to sevoflurane may be associated with calcium release from the sarcoplasmic reticulum. We present here a case of rarely-seen delayed MH induced by an inhalation agent of low-inducing probability, sevoflurane, after the second exposure to which within a short period of time. The patient was a five years old boy who received sevoflurane anesthesia for repeat orthopedic surgery within two days. Gradual elevation in heart rate, abrupt hypercarbia and hyperthermia were observed 90 min after induction. Dantrolene was administrated immediately with effective therapeutic response. Eventually, the patient recovered without any complication as an aftermath. Gradually elevated heart rate during the second exposure to sevoflurane was the atypical sign in the episode of MH in this case. One plausible explanation for the development of delayed onset of MH is the latent effect of the volatile anesthetic on the skeletal muscles. Therefore, it is worth noting for the anesthesiologists to recognize the possibility of an atypical MH and be alert for the possible occurrence of MH during routine anesthetic practice.
Chen
Po-Liang
PL
Department of Anesthesiology, Chang Gung Memorial Hospital, Linko, Taiwan, ROC.
Day
Yuan-Ji
YJ
Su
Bai-Chuan
BC
Lee
Po-Cheng
PC
Chen
Chun-Yu
CY
D018685:Anesthetics, Inhalation / Q000009:adverse effects*; D002675:Child, Preschool; D006801:Humans; D008297:Male; D008305:Malignant Hyperthermia / Q000209:etiology*; D008738:Methyl Ethers / Q000009:adverse effects*; D000077149:Sevoflurane; D013997:Time Factors
D018685:Anesthetics, Inhalation; D008738:Methyl Ethers; D000077149:Sevoflurane